New Issue: Memorial Sloan-Kettering Cancer Center, N.Y., prices $250 million bonds

By Sheri Kasprzak

New York, Dec. 5 - The Memorial Sloan-Kettering Cancer Center of New York priced $250 million of series 2011A taxable bonds, according to a pricing sheet. The offering was downsized from $400 million.

The bonds (Aa2/AA-/AA) were sold through Goldman, Sachs & Co. with J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC as the co-managers.

The bonds are due July 1, 2042, and bear interest at 5% priced at par.

Proceeds will be used to fund capital projects for the cancer center.

Issuer:	Memorial Sloan-Kettering Cancer Center
Issue:	Series 2011A taxable bonds
Amount:	$250 million
Maturity:	July 1, 2042
Coupon:	5%
Price:	100
Type:	Negotiated
Underwriters:	Goldman, Sachs & Co. (lead), J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC (co-managers)
Ratings:	Moody's: Aa2
	Standard & Poor's: AA-
	Fitch: AA
Pricing date:	Dec. 1
Settlement date:	Dec. 8

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.